Epitope-based precision immunotherapy of Type 1 diabetes.
Epitope-based precision immunotherapy of Type 1 diabetes.
复制标题
DOI:
10.1080/21645515.2022.2154098
复制
发表时间:
2023-12-31
影响因子:
4.8
通讯作者:
中科院分区:
文献类型:
--
作者:
Antigen-specific immunotherapies (ASITs) address important clinical needs in treating autoimmune diseases. However, Type 1 diabetes is a heterogeneous disease wherein patient characteristics influence responsiveness to ASITs. Targeting not only disease-relevant T cell populations, but also specific groups of patients using precision medicine is a new goal toward achieving effective treatment. HLA-restricted peptides provide advantages over protein as antigens, however, methods for profiling antigen-specific T cells need to improve in sensitivity, depth, and throughput to facilitate epitope selection. Delivery approaches are highly diverse, illustrating the many ways relevant antigen-presenting cell populations and anatomical locations can be targeted for tolerance induction. The role of persistence of antigen presentation in promoting durable antigen-specific tolerance requires further investigation. Based on the outcome of ASIT trials, the field is moving toward using patient-specific variations to improve efficacy, but challenges still lie on the path to delivering more effective and safer treatment to the T1D patient population.
登录
查看更多内容
DOI:
10.1126/science.aad2791
发表时间:
2016-02-12
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Delong T;Wiles TA;Baker RL;Bradley B;Barbour G;Reisdorph R;Armstrong M;Powell RL;Reisdorph N;Kumar N;Elso CM;DeNicola M;Bottino R;Powers AC;Harlan DM;Kent SC;Mannering SI;Haskins K
通讯作者:
Haskins K
影响因子:
5.5
作者:
通讯作者:
--
影响因子:
82.9
作者:
通讯作者:
--
影响因子:
17.1
作者:
Akbarpour, Mahzad;Goudy, Kevin S.;Roncarolo, Maria Grazia
通讯作者:
Roncarolo, Maria Grazia
影响因子:
64.8
作者:
Clemente-Casares, Xavier;Blanco, Jesus;Santamaria, Pere
通讯作者:
Santamaria, Pere